Kangmei Pharmaceutical Co Ltd (600518) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.030x

Based on the latest financial reports, Kangmei Pharmaceutical Co Ltd (600518) has a cash flow conversion efficiency ratio of 0.030x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥219.96 Million ≈ $32.19 Million USD) by net assets (CN¥7.22 Billion ≈ $1.06 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Kangmei Pharmaceutical Co Ltd (600518) net asset quality to measure how much of total assets are equity-financed.

Kangmei Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2024)

This chart illustrates how Kangmei Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Kangmei Pharmaceutical Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Kangmei Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kangmei Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
ArcBest Corp
NASDAQ:ARCB
0.007x
CCC S.A.
WAR:CCC
0.290x
Gujarat Gas Limited
NSE:GUJGASLTD
0.054x
Lagardere SCA
PA:MMB
0.943x
Gold Road Resources Ltd
AU:GOR
0.122x
Joincare Pharmaceutical Group Industry Co Ltd
SHG:600380
0.044x
Viscofan
MC:VIS
0.066x
China Leadshine Technology Co Ltd
SHE:002979
0.074x

Annual Cash Flow Conversion Efficiency for Kangmei Pharmaceutical Co Ltd (1999–2024)

The table below shows the annual cash flow conversion efficiency of Kangmei Pharmaceutical Co Ltd from 1999 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Kangmei Pharmaceutical Co Ltd.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥7.21 Billion
≈ $1.05 Billion
CN¥-427.63 Million
≈ $-62.58 Million
-0.059x -32.28%
2023-12-31 CN¥7.08 Billion
≈ $1.04 Billion
CN¥-317.52 Million
≈ $-46.46 Million
-0.045x +58.58%
2022-12-31 CN¥6.93 Billion
≈ $1.01 Billion
CN¥-749.96 Million
≈ $-109.74 Million
-0.108x -603.84%
2021-12-31 CN¥9.97 Billion
≈ $1.46 Billion
CN¥214.21 Million
≈ $31.34 Million
0.021x +121.69%
2020-12-31 CN¥-10.41 Billion
≈ $-1.52 Billion
CN¥1.03 Billion
≈ $150.93 Million
-0.099x -171.00%
2019-12-31 CN¥20.65 Billion
≈ $3.02 Billion
CN¥2.88 Billion
≈ $421.73 Million
0.140x +1092.59%
2018-12-31 CN¥26.12 Billion
≈ $3.82 Billion
CN¥305.62 Million
≈ $44.72 Million
0.012x +106.89%
2017-12-31 CN¥28.52 Billion
≈ $4.17 Billion
CN¥-4.84 Billion
≈ $-708.25 Million
-0.170x -411.09%
2016-12-31 CN¥29.38 Billion
≈ $4.30 Billion
CN¥1.60 Billion
≈ $234.60 Million
0.055x +101.99%
2015-12-31 CN¥18.84 Billion
≈ $2.76 Billion
CN¥508.86 Million
≈ $74.46 Million
0.027x -60.11%
2014-12-31 CN¥16.72 Billion
≈ $2.45 Billion
CN¥1.13 Billion
≈ $165.68 Million
0.068x -51.33%
2013-12-31 CN¥12.03 Billion
≈ $1.76 Billion
CN¥1.67 Billion
≈ $244.96 Million
0.139x +46.04%
2012-12-31 CN¥10.58 Billion
≈ $1.55 Billion
CN¥1.01 Billion
≈ $147.55 Million
0.095x +53.26%
2011-12-31 CN¥9.25 Billion
≈ $1.35 Billion
CN¥574.96 Million
≈ $84.14 Million
0.062x -54.24%
2010-12-31 CN¥4.93 Billion
≈ $720.79 Million
CN¥669.19 Million
≈ $97.92 Million
0.136x +385.79%
2009-12-31 CN¥4.27 Billion
≈ $625.11 Million
CN¥119.47 Million
≈ $17.48 Million
0.028x +2604.86%
2008-12-31 CN¥2.92 Billion
≈ $426.72 Million
CN¥3.02 Million
≈ $441.19K
0.001x -98.52%
2007-12-31 CN¥2.32 Billion
≈ $339.36 Million
CN¥162.55 Million
≈ $23.79 Million
0.070x +18.58%
2006-12-31 CN¥1.16 Billion
≈ $169.13 Million
CN¥68.32 Million
≈ $10.00 Million
0.059x -74.53%
2005-12-31 CN¥573.59 Million
≈ $83.93 Million
CN¥133.13 Million
≈ $19.48 Million
0.232x +51.30%
2004-12-31 CN¥511.88 Million
≈ $74.90 Million
CN¥78.52 Million
≈ $11.49 Million
0.153x -13.01%
2003-12-31 CN¥442.44 Million
≈ $64.74 Million
CN¥78.02 Million
≈ $11.42 Million
0.176x +29.03%
2002-12-31 CN¥391.23 Million
≈ $57.25 Million
CN¥53.47 Million
≈ $7.82 Million
0.137x +218.04%
2001-12-31 CN¥365.10 Million
≈ $53.43 Million
CN¥15.69 Million
≈ $2.30 Million
0.043x -55.15%
2000-12-31 CN¥103.96 Million
≈ $15.21 Million
CN¥9.96 Million
≈ $1.46 Million
0.096x -64.81%
1999-12-31 CN¥111.12 Million
≈ $16.26 Million
CN¥30.25 Million
≈ $4.43 Million
0.272x --

About Kangmei Pharmaceutical Co Ltd

SHG:600518 China Drug Manufacturers - Specialty & Generic
Market Cap
$2.69 Billion
CN¥18.39 Billion CNY
Market Cap Rank
#5154 Global
#869 in China
Share Price
CN¥1.33
Change (1 day)
-2.92%
52-Week Range
CN¥1.20 - CN¥2.20
All Time High
CN¥27.48
About

Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese herbal medicines in China. The company offers Chinese patent medicines, chemical medicines, and health food products. In addition, it engages in the operation of Chinese medicinal materials markets; production and sale of medical devices; and operation of pharmaceutical logistics system. The company provides its products through medical … Read more